Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
NCT06581523
Summary
The goal of this feasibility study and clinical trial is to learn if an evidenced-based breathwork and meditation intervention (SKY Breath) will improve the mental and physical well-being of individuals with Parkinson's Disease (iPD) in stages 1, 2, and 3, under the age of 75 and their care partners. The main questions it aims to answer are: * Objective 1: Can the SKY Breath practice be designed and implemented to specifically cater to the unique needs of individuals with Parkinson's Disease and their care partners. * Objective 2: Will the SKY Breath practice decrease stress levels (a contributor to increasing PD symptoms) for individuals with Parkinson\'s Disease (iPD) and their care partners as measured through self-reported surveys to improve overall well-being and quality of life. * Objective 3: Will the SKY Breath practice in part alleviate the emotional stress and physical burden experienced by care partners of PD patients, promoting their resilience and well-being. Participants will be asked to learn the SKY Breath and Meditation practice over the course of 4 days (2.25 hours each morning), practice SKY every day for 4 weeks and keep a log of time spent doing SKY. The participants will complete a series of surveys before learning the practice and then after at weeks 1, 4 and 8. The series of surveys will take about 20 minutes.
Eligibility
Inclusion Criteria: Individuals with Parkinson's Disease (iPD) Inclusion Criteria: An individual with a formal diagnosis of iPD that: * are in stages 1, 2, or 3 * are at least 18 years of age * are no older than 75 years of age * can understand, read, write and speak English at a 5th grade level * that have access to zoom sessions online via laptop, ipad or other mobile device * are able to secure reliable transportation for themselves. Care Partner of the individuals with Parkinson's Disease (iPD) Inclusion Criteria: Individuals who: * are a care partner for an individual with Parkinson's Disease but are not paid professional givers of care * are at least 18 years of age or older * are able to secure reliable transportation for themselves and for the Individual with Parkinson's Disease * can understand, read, write and speak English at a 5th grade level * has access to zoom sessions online via laptop, iPad or other mobile device. Exclusion Criteria: Individuals with Parkinson's Disease (iPD): An individual who * has been diagnosed with Parkinson's Disease that is in stages 4 or 5 of the disease * is younger that age 18 or older than age 75 * has bipolar disorder * has seizure disorder * has schizophrenia or schizoaffective disorder * has active substance use * has uncontrolled hypertension * has cognitive impairment that prevents them from memorizing (remembering) the steps to complete the daily breath and meditation practice or completing the survey instruments, or has difficulty following sequential directions of the breathing practice * cannot understand, read, write and speak English at a 5th grade level * does not have access to zoom sessions online via laptop, iPad or other mobile device * can not secure transportation to the site for the training of the breath and meditation practice Care partner of the Individuals with Parkinson's Disease (iPD): Individuals who: * are paid professional givers of care * are under the age of 18 * an emancipated minor * have bipolar disorder * have seizure disorder * have schizophrenia or schizoaffective disorder * have active substance use * have uncontrolled hypertension * are not able to secure reliable transportation for themselves * cannot understand, read, write and speak English at a 5th grade level * does not have access to access to zoom sessions online via laptop, iPad or other mobile device.
Conditions1
Locations3 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06581523